Ferritin Quantitative Test

SARS-CoV-2 Antigen Rapid Qualitative Test

The SARS-CoV-2 Antigen Rapid Qualitative Test is a colloidal gold immunochromatography intended for the qualitative detection of nucleocapsid antigens from SARS-CoV-2 in human nasal swabs, throat swabs, and sputum from individuals who are suspected of COVID-19 by their healthcare provider. within the first five days of the onset of symptoms.
Product Detail

Product Features

High sensitivity and specificity

Test results conveniently available in 20-30 minutes

Long shelf life of 24 months with room temperature storage

QR-code based patient tracking


Clinical Performance

Relative Sensitivity: 96.00% (88.75% - 99.17%)

Relative Specificity: 100.00% (98.34% - 100.00%)

Accuracy: 98.98% (97.06 – 99.79%)



Testing process for the SARS-CoV-2 Rapid Antigen Test

 

① Transfer 6 drops of extraction buffer to a tube.

② Insert the swab into an extraction buffer tube. While squeezing the buffer tube, stir the swab more than 10 seconds.

③ Remove the swab while squeezing the sides of the tube to extract the liquid from the swab.

④ Press the nozzle cap tightly onto the tube. Continue with 3a. Performing a test.

⑤ Place the test device on a flat surface and apply 2 drops of extracted sample in a 90° angle to the specimen well of the cassette

⑥ Read the test result at 20 to 30 mins.



Interpreting Test Results




Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
SARS-CoV-2 IgG/IgM Rapid Test
SARS-CoV-2 IgG/IgM Rapid Qualitative Test
The Biotime SARS-CoV-2 IgG/IgM Rapid Qualitative Test is intended to qualify the SARS-CoV-2 IgG and IgM antibody in human plasma, serum or whole blood by colloidal gold immunochromatography assay. The test can be used as an aid detection to SARS-CoV-2 infection and thus caused COVID-19 disease.
Neutralizing Antibody Rapid Test
SARS-CoV-2 Neutralizing Antibody Rapid Test
Biotime SARS-CoV-2 Neutralizing Antibody rapid test is a fluorescence immunoassay(FIA) for the qualitative detection of total neutralizing antibodies to SARS-CoV-2 in human serum or plasma. It is useful as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
HbA1c Analyzer
HLC-100 Fully Automated HbA1c Analyzer
Biotime’s HLC-100 Fully Automated HbA1c Analyzer provides a prompt, reliable solution for diabetes diagnosis. It utilizes the high performance liquid chromatography (HPLC) analytical technique, a gold standard that helps detect glycosylated hemoglobin (HbA1c) with superior precision. Its capability to measure HbA1c, HbF, and other hemoglobin fragments enables clinicians to make quick, accurate diagnoses, thus facilitating timely treatment for the patient.
Cys C Rapid Quantitative Test
Cys-C Rapid Quantitative Test
Serum Cystatin C(Cys-C) has been proposed as a marker of glomerular filtration rate(GFR). Serum creatinine (creatinine) is widely used to estimate the glomerular filtration rate, but its tubular secretion, dependence on muscle mass, alteration in some inflammatory diseases, and analytical interferences can limit its utility. Thus, Cys-C has been proposed as a novel biomarker of kidney function.
Rubella IgG/IgM Rapid Test (Fluorescence Immunoassay)
Rubella IgG/IgM Rapid Test (Fluorescence Immunoassay)
TheRubella IgG/IgM Rapid Test is an in vitro immunoassay for the in vitro qualitative determination of IgG and IgM class antibodies toRubella in human serum.IgG results with this assay are used to indicate past or recent infection withRubella. IgM results obtained with this assay are used as an aid in the diagnosis of acute or recent Rubella infections. Rubella IgM test shall not be used for prenatal screening of asymptomatic people, and the test results of this reagent shall not be used alone as the basis for termination of pregnancy.
Incubation Chamber
ICE-100E Incubation Chamber
The incubation chamber is an auxiliary device for Biotime’s fluorescence immunoassay analyzer. The reaction temperature and time is critical for test results. The incubation chamber provides an optimized environment as well as automatic timers for test reactions to improve the reliability of test results.
Biotime CKMB Rapid Quantitative Test
CK-MB Rapid Quantitative Test
CK-MB is very valuable for the early diagnosis of AMI. The Biotime CK-MB test kit can perform the test accurately and rapidly within 15 minutes with Biotime Analyzers.
Biotime 5 in 1  cTnI  CK-MB Myo  NTproBNP  D Dimer rapid fluorescence immunoassay test
5 in 1 (cTnI/ CK-MB/ Myo/ NT-proBNP/ D-Dimer) Rapid Quantitative Test
Cardiac markers are used in the diagnosis and risk stratification of patients with chest pain, suspected Acute Coronary Syndrome(ACS) and Heart Failure(HF), etc.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact